Share General Information
Fulvestrant is used in the treatment of hormone-sensitive advanced breast cancer in postmenopausal women.
About the API
Technology
High Potent
Therapeutic category
Oncology
Available formulations
Injectables
Injectables Long-Acting
Regulations
-
Japan DMF
-
Korea DMF
-
US DMF
Updates About Fulvestrant
December 19, 2016
New IN DMF dated 12/2016 is available.
The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.
For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.
